Stocks and Investing Stocks and Investing
Tue, February 28, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Stevenson Maintained (TREX) at Hold with Increased Target to $55 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Taylor Conrad Maintained (TSCO) at Strong Buy with Increased Target to $260 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
James Friedman Downgraded (TREE) to Hold and Held Target at $36 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Nat Schindler Maintained (TREE) at Strong Buy with Decreased Target to $43 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Jed Kelly Maintained (TREE) at Buy with Increased Target to $40 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Bose George Maintained (TREE) at Hold with Increased Target to $34 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Feldman Reiterated (TGT) at Buy and Held Target at $185 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Robert Ohmes Maintained (TGT) at Hold and Held Target at $180 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Joshua Wilson Maintained (TGLS) at Hold with Increased Target to $42 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Curry Baker Maintained (TGNA) at Strong Buy with Decreased Target to $22 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Reiterated (TDUP) at Buy and Held Target at $3 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Ronald Epstein Maintained (TDG) at Strong Buy and Held Target at $890 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Daniel Grosslight Maintained (TDOC) at Hold with Decreased Target to $30 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (TASK) at Hold with Decreased Target to $19 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Maintained (TASK) at Sell with Decreased Target to $16 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Douglas Tsao Reiterated (TBPH) at Strong Buy and Held Target at $19 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Shyam Patil Maintained (TBLA) at Hold with Increased Target to $3 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Emily Bodnar Initiated (AGEN) at Strong Buy and Held Target at $160 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
David Saxon Reiterated (ALC) at Strong Buy and Held Target at $85 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Aaron Hecht Maintained (AMH) at Hold with Decreased Target to $38 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Fein Reiterated (BPMC) at Strong Buy and Held Target at $70 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Ami Fadia Reiterated (BPMC) at Strong Buy and Held Target at $57 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Benjamin Chaiken Reiterated (BPMC) at Hold and Held Target at $114 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Blair Abernethy Reiterated (BSY) at Strong Buy and Held Target at $39 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Ryan Todd Initiated (CLNE) at Buy and Held Target at $8 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Kaumil Gajrawala Upgraded (CELH) to Buy and Increased Target to $40 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Kieran De Brun Maintained (CE) at Hold with Increased Target to $113 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (CE) at Buy with Decreased Target to $131 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
John McNulty Maintained (CE) at Buy with Decreased Target to $146 on, Feb 28th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Sykes Maintained (CDNA) at Strong Buy with Decreased Target to $25 on, Feb 28th, 2023

Matthew Sykes Maintained (CDNA) at Strong Buy with Decreased Target to $25 on, Feb 28th, 2023


Published on 2024-10-28 01:58:45 - WOPRAI, Matthew Sykes
  Print publication without navigation


Matthew Sykes of Goldman Sachs, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Decreased Target from $29 to $25 on, Feb 28th, 2023.

Matthew has made no other calls on CDNA in the last 4 months.



There is 1 other peer that has a rating on CDNA. Out of the 1 peers that are also analyzing CDNA, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Andrew Cooper of "Raymond James" Maintained at Strong Buy with Decreased Target to $24 on, Tuesday, January 31st, 2023
Contributing Sources